Lowering urate cuts cardiovascular deathsHyperuricemia deserves more aggressive treatment, researcher says Early treatment improves outcomes in rheumatoid arthritisMethotrexate-prednisone combo achieves remission in nearly two-thirds of patients Rheumatoid arthritis biologics may provoke shingles outbreaks Researchers advise clinicians to be vigilant when prescribing anti-TNF therapy Osteoporosis: There’s an app for that New Canadian guidelines offer a choice of risk assessment tools Uloric: first new option for gout in more than 40 years Takeda Canada will soon be introducing Uloric (febuxostat 80 mg) tablets, the first new drug to be marketed for gout in more than four decades. Men and Women's Health 2010: Osteoporosis New developments in therapy, vitamin D requirements, bisphosphonate safety and risk assessment. Actemra: anaphylaxis risk Hoffmann-La Roche and Health Canada warn about potential risk of fatal anaphylaxis with Actemra (tocilizumab). Arthritis care benefits from team approach Leading Ontario clinic spreading its model of chronic disease management across Canada Rheumatoid arthritis redefined Canadian doctor played a major role in international effort to overhaul RA criteria Drinking decreases arthritis risk Study links alcohol consumption with reduced likelihood of several inflammatory conditions First Previous 17 18 19 20 Next Last
